FAIRFIELD, Conn., June 2, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) today announced that it has signed an agreement to raise over $5 million by selling 2 million shares of equity to Crisnic Fund, S.A. based on a 15% discount from the volume weighted average price on the date the SEC declares the registration effective, as detailed in the 8-K being filed today. The funds raised will provide financing for CTT to more aggressively sell its innovative Calmare® Pain Therapy Treatment, which treats chronic neuropathic and oncologic pain, both in the U.S. and internationally
